Detection of some β-lactamase Genes in Klebsiella pneumoniae Isolated from some Baghdad Hospitals, Iraq

Authors

  • ALI Y. Hussein Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq. https://orcid.org/0009-0009-1505-0207
  • Ban O. Abdulsattar Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq. https://orcid.org/0000-0003-0630-4809
  • Nadal A. Al-Saryi Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq. https://orcid.org/0000-0003-1112-1476
  • Wadhah H. Edrees Medical Microbiology Department, Faculty of Applied Sciences, Hajjah University, Yemen, and Medical Laboratory Department, Faculty of Medical Sciences, Queen Arwa University, Yemen. https://orcid.org/0000-0002-7799-0466

DOI:

https://doi.org/10.23851/mjs.v35i2.1472

Keywords:

Klebsiella pneumoniae, MDR, β-lactamase, blaNDM, blaT EM

Abstract

Background: Multi-Drug-Resistant Klebsiella pneumoniae (MDR K. pneumoniae) is considered as an important opportunistic pathogen, which causes life threatening infections. K. pneumoniae is known to causes life-threatening infections. Objective: The objective of this study is to detect some β-lactamase genes inKlebsiella pneumoniae. Methods: Thirty-five K. pneumoniae isolates were obtained from some hospitals in Baghdad City between October 2022 and February 2023. The identification of K. pneumoniae isolates was done phenotypically by the automated VITEK II system and genotypically by amplification of the rpob gene. The antibiotic susceptibility and detection of some β-lactamase genes were tested for all isolates. Results: The results showed that the K. pneumoniae isolates were resistant to most antibiotics used. A high percentage of K. pneumoniae isolates were resistant to cefixime, cefpodoxime, norfloxacin and doxycycline as 100% followed by ceftriaxone, ceftazidime, ticarcillin/clavulanate, ticarcillin, ceftazidime, tobramycin, and moxifloxacin (97.2%, 91.7%, 91.7%, 94.4%, 94.4%, and 94.4%, respectively). Furthermore, approximately 94.4% of the isolates were MDR. In addition, the molecular methods only detected the blaNDM and blaT EM genes as 33.3% and 75.6% of in the K. pneumoniae isolates, respectively, while the blaV IM, blaCTX−M, and blaKP C genes were not observed in K. pneumoniae isolates. Conclusions: β-lactam antibiotics, including carbapenems, are widely used to treat bacterial infections; however, an increase in antibiotic resistance due to β-lactamases limits the effectiveness of these antibiotics. Therefore, alternative treatment methods are required to control these resistant isolates.

Downloads

Download data is not yet available.

References

S. Harada, K. Aoki, S. Yamamoto, Y. Ishii, N. Sekiya, H. Kurai, K. Furukawa, A. Doi, K. Tochitani, and K. Kubo,"Clinical and molecular characteristics of klebsiella pneumoniae isolates causing bloodstream infections in japan: Occurrence of hypervirulent infections in health care," Journal of Clinical Microbiology, vol. 57, no. 11, e01206-19, 2019.

CrossRef | PubMed

R. M. Martin, J. Cao, S. Brisse, V. Passet, W. Wu, L. Zhao, P. N. Malani, K. Rao, and M. A. Bachman, "Molecular epidemiology of colonizing and infecting isolates of klebsiella pneumoniae," mSphere, vol. 1, no. 5, e00261-16, 2016.

CrossRef | PubMed

R. Podschun and U. Ullmann, "Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors," Clinical Microbiology Reviews, vol. 11, no. 4, pp. 589-603, 1998.

CrossRef | PubMed

J. E. Choby, J. Howard-Anderson, and D. S. Weiss, "Hypervirulent klebsiella pneumoniae-clinical and molecular perspectives," Journal of Internal Medicine, vol. 287, no. 3, pp. 283-300, 2020.

CrossRef | PubMed

D. Chang, L. Sharma, C. S. Dela Cruz, and D. Zhang, "Clinical epidemiology, risk factors, and control strategies of klebsiella pneumoniae infection," Frontiers in Microbiology, p. 3955, 2021.

CrossRef | PubMed

S. Basak, P. Singh, and M. Rajurkar, "Multidrug resistant and extensively drug resistant bacteria: A study," Journal of Pathogens, vol. 2016, 2016.

CrossRef | PubMed

B. Kot, M. Piechota, P. Szweda, J. Mitrus, J. Wicha, A. Grużewska, and M. Witeska, "Virulence analysis and antibiotic resistance of klebsiella pneumoniae isolates from hospitalised patients in poland," Scientific Reports, vol. 13, no. 1, p. 4448, 2023.

CrossRef | PubMed

A. Spadar, J. Phelan, R. Elias, A. Modesto, C. Caneiras, C. Marques, L. Lito, M. Pinto, P. Cavaco-Silva, and H. Ferreira, "Genomic epidemiological analysis of klebsiella pneumoniae from portuguese hospitals reveals insights into circulating antimicrobial resistance," Scientific Reports, vol. 12, no. 1, pp. 1-13, 2022.

CrossRef | PubMed

K. Bush and G. A. Jacoby, "Updated functional classification of β-lactamases," Antimicrobial Agents and Chemotherapy, vol. 54, no. 3, pp. 969-976, 2010.

CrossRef | PubMed

D. L. Paterson and R. A. Bonomo, "Extended-spectrum β-lactamases: A clinical update," Clinical Microbiology Reviews, vol. 18, no. 4, pp. 657-686, 2005.

CrossRef | PubMed

G. Meletis, "Carbapenem resistance: Overview of the problem and future perspectives," Therapeutic Advances in Infectious Disease, vol. 3, no. 1, pp. 15-21, 2016.

CrossRef | PubMed

M. Shyaula, C. Khadka, P. Dawadi, and M. R. Banjara, "Systematic review and meta-analysis on extendedspectrum β-lactamases producing klebsiella pneumoniae in nepal," Microbiology Insights, vol. 16, p. 11 786 361 221 145 179, 2023.

CrossRef | PubMed

A. A. Dashti, M. M. Jadaon, A. M. Abdulsamad, and H. M. Dashti, "Heat treatment of bacteria: A simple method of dna extraction for molecular techniques," Kuwait Medical Journal, vol. 41, no. 2, pp. 117-122, 2009.

M. Masaeli, T. Faraji, R. Ramazanzadeh, N. Amirmozafari, M. Mansouri, and B. Mohsenpor, "Risk factors associated with resistance in ctx-m producing e. coli isolates," Current Drug Therapy, vol. 7, no. 2, pp. 138-143, 2012.

CrossRef

M. H. Al-Agamy, A. M. Shibl, M. S. Ali, H. Khubnani, H. H. Radwan, and D. M. Livermore, "Distribution of β-lactamases in carbapenem-non-susceptible acinetobacter baumannii in riyadh, saudi arabia," Journal of Global Antimicrobial Resistance, vol. 2, no. 1, pp. 17-21, 2014.

CrossRef | PubMed

L. Poirel, T. R. Walsh, V. Cuvillier, and P. Nordmann, "Multiplex pcr for detection of acquired carbapenemase genes," Diagnostic Microbiology and Infectious Disease, vol. 70, no. 1, pp. 119-123, 2011.

CrossRef | PubMed

M. Colomer-Lluch, L. Imamovic, J. Jofre, and M. Muniesa, "Bacteriophages carrying antibiotic resistance genes in fecal waste from cattle, pigs, and poultry," Antimicrobial Agents and Chemotherapy, vol. 55, no. 10, pp. 4908-4911, 2011.

CrossRef | PubMed

I. M. M. Alansary and N. A. Al-Saryi, "Detection of biofilm formation in classical and hypervirulent klebsiella pneumoniae," Al-Mustansiriyah Journal of Science, vol. 33, no. 5, pp. 65-71, 2022.

CrossRef

Y. He, X. Guo, S. Xiang, J. Li, X. Li, H. Xiang, J. He, D. Chen, and J. Chen, "Comparative analyses of phenotypic methods and 16s rrna, khe, rpob genes sequencing for identification of clinical isolates of klebsiella pneumoniae," Antonie Van Leeuwenhoek, vol. 109, pp. 1029-1040, 2016.

CrossRef | PubMed

P. Aminul, S. Anwar, M. A. Molla, and M. A. Miah, "Evaluation of antibiotic resistance patterns in clinical isolates of klebsiella pneumoniae in bangladesh," Biosafety and Health, vol. 3, no. 6, pp. 301-306, 2021.

CrossRef

D. P. Nicolau, "Carbapenems: A potent class of antibiotics," Expert Opinion on Pharmacotherapy, vol. 9, no. 1, pp. 23-37, 2008.

CrossRef | PubMed

C.-R. Lee, J. H. Lee, K. S. Park, Y. B. Kim, B. C. Jeong, and S. H. Lee, "Global dissemination of carbapenemaseproducing klebsiella pneumoniae: Epidemiology, genetic context, treatment options, and detection methods," Frontiers in Microbiology, p. 895, 2016. doi: 10.3389/fmicb.2016.00895.

CrossRef

M. Götte, A. Berghuis, G. Matlashewski, M. A. Wainberg, and D. Sheppard, Handbook of antimicrobial resistance. Springer, 2017.

CrossRef

S. E. Boyd, D. M. Livermore, D. C. Hooper, and W. W. Hope, "Metallo-β-lactamases: Structure, function, epidemiology, treatment options, and the development pipeline," Antimicrobial Agents and Chemotherapy, vol. 64, no. 10, e00397-20, 2020.

CrossRef | PubMed

A. B. Mohammed and K. A. Anwar, "Phenotypic and genotypic detection of extended spectrum beta lactamase enzyme in klebsiella pneumoniae," PLOS ONE, vol. 17, no. 9, e0267221, 2022.

CrossRef | PubMed

Downloads

Additional Files

Key Dates

Received

03-09-2023

Revised

06-12-2023

Accepted

26-12-2023

Published

30-06-2024

Data Availability Statement

None

Issue

Section

Original Article

How to Cite

[1]
A. Y. Hussein, B. O. Abdulsattar, N. A. . Al-Saryi, and W. H. . Edrees, “Detection of some β-lactamase Genes in Klebsiella pneumoniae Isolated from some Baghdad Hospitals, Iraq”, Al-Mustansiriyah J. Sci., vol. 35, no. 2, pp. 52–60, Jun. 2024, doi: 10.23851/mjs.v35i2.1472.

Similar Articles

1-10 of 238

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)